Akari Therapeutics Reports First Quarter 2019 Financial Results And Highlights Recent Clinical Progress

    NEXT STORY
    Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board
    PREV STORY
    TYME Provides Business Update and Reports Fourth Quarter and Fiscal Year 2019 Financial and Operating Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Karyopharm Initiates Second Generation SINE™ Compound Clinical Trial in Multiple Myeloma

    NEWTON, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    VendEngine Partners with The Family Center to Offer Programs to Build Better Lives

    author_avatar
    NASDAQ Market News

    SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19

    author_avatar
    NASDAQ Market News